GlassScriptPhysician profile
Mark Nathan Belkin
NPI 1023499498
$27,919.99
in general payments reported to CMS, 2019-2025
33 companies · $9,537 in 2025
The $9,537 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,333 · 2020: $460 · 2021: $12K · 2022: $1,111 · 2023: $1,722 · 2024: $1,408 · 2025: $9,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,350 · Food and Beverage: $4,866 · Travel and Lodging: $451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,350.00 |
| Food and Beverage | $4,865.68 |
| Travel and Lodging | $450.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $14,168.17 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Amplatzer Amulet |
| Bayer Healthcare Pharmaceuticals INC. | $7,628.69 | 2023-2025 | |
| Medtronic, INC. | $1,418.39 | 2021-2025 | Selectsecure |
| Aop Health US, LLC | $1,082.02 | 2025 | Rapiblyk |
| Cvrx, INC. | $639.30 | 2021-2025 | Barostim Neo System |
| Abiomed | $472.32 | 2019-2025 | Impella |
| Endotronix, INC. | $294.31 | 2023-2025 | Cordella Pulomonary Artery Pressure Sensor, Cordella Pulmonary Artery Pressure Sensor |
| Astrazeneca Pharmaceuticals LP | $290.01 | 2020-2025 | Farxiga, Brilinta, Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $245.03 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $188.45 | 2021-2025 | |
| Pfizer INC. | $171.32 | 2019-2025 | |
| Boston Scientific Corporation | $144.85 | 2019-2020 | |
| Amgen INC. | $139.57 | 2019-2023 | Repatha |
| Paragonix Technologies, INC. | $138.11 | 2024 | Sherpapak, Liverguard, Pancreaspak |
| Medtronic Vascular, INC. | $137.42 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $110.81 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $105.40 | 2019-2021 | |
| Daiichi Sankyo INC. | $79.91 | 2023 | Injectafer |
| Regeneron Healthcare Solutions, INC. | $69.54 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $59.65 | 2022-2024 | Camzyos |
| Bridgebio Pharma, INC. | $44.82 | 2025 | Attruby |
| Heartflow, INC. | $42.62 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.85 | 2023 | Jardiance |
| Zoll Circulation INC | $35.32 | 2021 | |
| Daxor Corporation | $33.92 | 2025 | Bva-100 |
| Merck Sharp & Dohme LLC | $33.85 | 2023 | Verquvo |
| Otsuka America Pharmaceutical, INC. | $24.47 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.62 | 2022 | |
| Alnylam Pharmaceuticals INC. | $21.51 | 2021 | |
| Medicomp INC | $19.62 | 2023 | Telepatch Cardiac Monitor |
| Lexicon Pharmaceuticals, INC. | $17.08 | 2023 | Inpefa |
| Procyrion, INC. | $4.04 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Belkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.